Issued Patents All Time
Showing 1–25 of 65 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 11884930 | Method of inactivating a glucocorticoid receptor gene in an isolated cell | Andreas Reik, Michael C. Jensen, Philip D. Gregory, Dale Ando | 2024-01-30 |
| 11793888 | Methods and compositions for engineering immunity | Brigit E. Riley | 2023-10-24 |
| 11648267 | Methods and compositions for gene inactivation | Dale Ando, Gary K. Lee | 2023-05-16 |
| 11591622 | Method of making and using mammalian liver cells for treating hemophilia or lysosomal storage disorder | Thomas Wechsler | 2023-02-28 |
| 11492643 | Methods and compositions for treatment of a genetic condition | Gregory J. Cost, Philip D. Gregory, Dmitry Guschin, Jeffrey C. Miller, David Paschon +4 more | 2022-11-08 |
| 11439666 | Targeted disruption of T cell receptor genes using engineered zinc finger protein nucleases | Maria Chiara Bonini, Pietro Genovese, Philip D. Gregory, Luigi Naldini, David Paschon +2 more | 2022-09-13 |
| 11311574 | Methods and compositions for targeted cleavage and recombination | Fyodor Urnov | 2022-04-26 |
| 11236175 | T cell modifying compounds and uses thereof | Philip D. Gregory | 2022-02-01 |
| 11235026 | Methods and compositions for modulating PD1 | Philip D. Gregory, Matthew C. Mendel, Xiangdong Meng, David Paschon, Andreas Reik +1 more | 2022-02-01 |
| 10918668 | Targeted disruption of T cell receptor genes using engineered zinc finger protein nucleases | Philip D. Gregory, David Paschon, Lei Zhang, Maria Chiara Bonini, Pietro Genovese +3 more | 2021-02-16 |
| 10907175 | Isolated human cell with an inactivated glucocorticoid receptor gene | Andreas Reik, Michael C. Jensen, Philip D. Gregory, Dale Ando | 2021-02-02 |
| 10858416 | Methods and compositions for modification of a HLA locus | Trevor Collingwood, Laurence J.N. COOPER, Philip D. Gregory, Jeffrey C. Miller, Edward J. Rebar +2 more | 2020-12-08 |
| 10717993 | Methods and compositions for increased transgene expression | Gary K. Lee | 2020-07-21 |
| 10675302 | Methods and compositions for targeted cleavage and recombination | Fyodor Urnov | 2020-06-09 |
| 10639383 | Methods and compositions for engineering immunity | Brigit E. Riley | 2020-05-05 |
| 10604771 | Delivery methods and compositions for nuclease-mediated genome engineering | Paula Cannon, Colin Exline | 2020-03-31 |
| 10494648 | Delivery methods and compositions for nuclease-mediated genome engineering | Jianbin Wang | 2019-12-03 |
| 10370680 | Method of treating factor IX deficiency using nuclease-mediated targeted integration | Thomas Wechsler | 2019-08-06 |
| 10155011 | Targeted disruption of T cell receptor genes using engineered zinc finger protein nucleases | Maria Chiara Bonini, Pietro Genovese, Philip D. Gregory, Luigi Naldini, David Paschon +2 more | 2018-12-18 |
| 10117899 | Delivery methods and compositions for nuclease-mediated genome engineering in hematopoietic stem cells | Pietro Genovese, Philip D. Gregory, Angelo Leone Lombardo, Luigi Naldini | 2018-11-06 |
| 10072062 | Methods and compositions for modification of a HLA locus | Trevor Collingwood, Laurence J.N. COOPER, Philip D. Gregory, Jeffrey C. Miller, Edward J. Rebar +2 more | 2018-09-11 |
| 10046028 | Methods and compositions for modulating PD1 | Philip D. Gregory, Matthew C. Mendel, Xiangdong Meng, David Paschon, Andreas Reik +1 more | 2018-08-14 |
| 9963715 | Methods and compositions for treatment of a genetic condition | Gregory J. Cost, Philip D. Gregory, Dmitry Guschin, Jeffrey C. Miller, David Paschon +4 more | 2018-05-08 |
| 9957526 | Delivery methods and compositions for nuclease-mediated genome engineering | Jianbin Wang | 2018-05-01 |
| 9937207 | Targeted disruption of T cell receptor genes using talens | Philip D. Gregory, David Paschon, Lei Zhang, Maria Chiara Bonini, Pietro Genovese +3 more | 2018-04-10 |